# OMEPRAZOLE MAGNESIUM
> **ANDA211732** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2020-03-25
## Drug
- **FDA Application Number:** ANDA211732
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OMEPRAZOLE MAGNESIUM
- **Generic name:** OMEPRAZOLE
- **Active ingredients:** OMEPRAZOLE MAGNESIUM
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** CHAIN DRUG MARKETING ASSOCIATION, INC.
- **First approval:** 2020-03-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211732)
---
*AI Analytics · CC0 1.0*